Last reviewed · How we verify
Marketed toothpaste
At a glance
| Generic name | Marketed toothpaste |
|---|---|
| Sponsor | Procter and Gamble |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Effectiveness of Test Dentifrice in the Relief of Dentinal Hypersensitivity (NA)
- A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation (NA)
- A Clinical Study Assessing the Effects of a Marketed Dentifrice on Tooth Sensitivity While Undergoing Tooth Bleaching (PHASE4)
- Assessing Gingivitis and Plaque From a Marketed Toothpaste (PHASE4)
- Determination of the Oral Irritation Potential of Two Alcohol-Free Rinses (NA)
- Determination of the Oral Irritation Potential of a Fluoride Rinse in Children (NA)
- Four-Week Oral Malodor and Clinical Safety for a Concentrated Cosmetic Mouthwash (NA)
- Probiotics That Moderate pH and Antagonize Pathogens to Promote Oral Health (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Marketed toothpaste CI brief — competitive landscape report
- Marketed toothpaste updates RSS · CI watch RSS
- Procter and Gamble portfolio CI